Emergent Medical Partners

What Emergent Medical Partners does

Emergent Medical Partners is a California-based venture capital firm focused exclusively on early-stage life science and medical device companies. The firm provides investment capital combined with hands-on expertise across the financial, medical, and engineering dimensions of medical device development, targeting entrepreneurs who require both funding and domain-specific guidance to commercialize innovations. Its portfolio spans over 30 medical device companies covering cardiovascular, orthopedic, imaging, oncology, sleep medicine, and surgical robotics subsectors, with active and exited positions dating back to at least 2009.

The firm does not develop proprietary technology, software, or products itself; its offering is an investment-plus-advisory partnership model. Portfolio companies have ranged from image-guided catheter systems (Avinger) and transcatheter mitral valve replacement devices (Twelve) to cloud-based medical imaging analytics (Arterys) and wireless neuromodulation platforms (Stimwave). The firm does not publicly disclose pricing, fund size, or AUM, and there is no software/SaaS product offering; monetization occurs through conventional venture capital mechanics (management fees and carried interest on invested capital), with returns realized via M&A exits and public listings.

The firm is led by Managing Director Thomas J. Fogarty, M.D., a cardiovascular surgeon and prolific medical device inventor (125+ patents), supported by partners with backgrounds in medtech operating leadership (Kirt Kirtland), corporate/securities law (Robert Brownell), and finance/administration (Kathy Tellyer). Notable exits have included acquisitions by Medtronic, Abbott Vascular, St. Jude Medical, Merit Medical, Hologic, Varian, Arthrex, Covidien, Volcano, and Intuitive Surgical, establishing a track record of liquidity events for portfolio companies.

Name

Emergent Medical Partners

Legal name

Emergent Medical Partners, LLP

Website

https://emvllp.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Emergent Medical Partners is a California-based venture capital firm that invests in and advises early-stage medical device and life science companies, providing funding alongside clinical, engineering, and regulatory expertise to support portfolio company development and exits.

Ownership category

akta.pro rank

Product category

Venture Capital — Medical Device Investment

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

Keywords

• Venture capital
• Medical device investment
• Life sciences funding
• Early-stage healthcare
• Medical device startups

Headquarters

HQ city

Portola Valley

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

Emergent Medical Partners is a California-based life sciences venture capital firm that provides funding and operational expertise to early-stage medical device and healthcare companies. The firm combines investment capital with deep clinical, regulatory, operational, and engineering guidance, sourced from its partners' backgrounds as surgeons, inventors, and medtech executives, to accelerate the development of portfolio companies in the medical device sector.

Product overview

Emergent Medical Partners is a venture capital firm that provides funding and expertise to early-stage life science entrepreneurs in the medical device sector. The company offers investment capital combined with expertise in financial, medical, and engineering facets of medical device development. Their service model supports portfolio companies through guidance on clinical, operational, legal, and financial challenges of growing life science companies, including navigation of the regulatory process. The company does not offer a distinct software product, platform, or SaaS offering; rather, it functions as an investment and advisory partnership that identifies and supports innovative medical device companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Device Venture Capital Investment
• Portfolio Company Advisory

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• OrbiMed: One of the largest dedicated healthcare/medical device venture capital firms, investing across stages in medical devices, biotech, and diagnostics. Highly comparable to Emergent as a specialist medtech investor with multi-cycle track record.
• Versant Ventures: Healthcare-focused venture firm with dedicated medical device and biotech franchises. Directly comparable to Emergent in stage focus, sector specialization, and strategy of building companies toward strategic acquisition.
• Novo Holdings (Novo Ventures): Permanent-capital healthcare/medical device investor backing early- and growth-stage companies globally. Comparable to Emergent as a long-duration, device-experienced specialist investor with operating-partner support.
• Forbion: European life sciences/medical device venture firm with multiple funds focused on building healthcare companies. Comparable to Emergent in sector focus and operator-led portfolio support, though with broader therapeutic breadth.
• Sofinnova Partners: Long-standing European healthcare/medtech venture firm with deep cardiovascular and surgical device experience. Comparable to Emergent in its focus on physician-inventors and medical device subspecialties.
• SightLine Partners: Medical-device-focused growth and venture investor backing commercial-stage device companies. Closely comparable to Emergent in its pure-play medical device specialization and operating-partner approach.
• BioStar Ventures: Medical-device-focused venture capital firm investing in early- and mid-stage cardiovascular and surgical device companies. Highly comparable to Emergent in fund size, sector focus, and stage.
• Catalyst Health Ventures: Early-stage medical device and digital health venture firm supporting commercialization-stage companies. Comparable to Emergent in its seed/Series A orientation and operational support model for device entrepreneurs.

Broad incumbents

• New Enterprise Associates (NEA): Large multi-stage venture firm with a dedicated healthcare practice actively investing in medical devices and healthtech. Comparable as a recurring acquirer-side counterparty for medtech startups, though much broader in sector mandate.
• Deerfield Management: Healthcare-dedicated investment firm with venture and structured-capital strategies across medical devices and biotech. Comparable as a large specialized healthcare investor, though broader in instrument types than Emergent.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments37 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emergent Medical Partners